Arbutus Biopharma Corp (ABUS) – cena akcií a novinky – Google Finance

Finance

DomovABUS • NASDAQ

Arbutus Biopharma Corp

4,26 $

16. 3., 8:20:34 GMT-4 · USD · NASDAQ · Vylúčenie

AkcieKrajina cenného papiera: USASídlo spoločnosti: USA

Predch. zatv. cena

4,26 $

Rozsah rokov

2,71 $ - 5,10 $

Trhová kapitalizácia

819,30 mil. USD

Priemerný objem

2,67 mil.

Cena/zisk

-

Dividendový výnos

-

Hlavná burza

NASDAQ

Novinky na trhu

pred 41 minútami

New to The Street Broadcasts Episode Featuring FreeCast (NASDAQ:CAST), KLED.AI, PetVivo (OTCQB:PETV), EmpowerLit, and BlackBarn NYC on Bloomberg Television - March 21 at 6:30 PM EST

pred 46 minútami

Cycurion (Nasdaq: CYCU) Announces Definitive Agreement to Acquire Federal Cybersecurity Firm and Reports Record Contracted Backlog Exceeding $150 Million

pred 50 minútami

Morgan Stanley's Mike Wilson: S&P 500 could trade toward 6,300 by early April

pred 55 minútami

Trump has 15 days to end the Iran war or markets face a brutal April repricing — from oil to the S&P 500

Severe oil shock could drag S&P 500 down to 5,400, Goldman warns

How do companies get added to (& dropped from) the Dow? The averages committee explained

Informácie

Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia

Generálny riaditeľ

William H. Collier

Dátum založenia

2007

Hlavné sídlo

Warminster Township, Pennsylvánia
Spojené štáty americké

Web

Zamestnanci

44

Vyhľadávanie

Vymazať vyhľadávanie

Zavrieť vyhľadávanie

Aplikácie Googlu

Hlavná ponuka